Pfizer (PFE) Treasury Shares (2009 - 2026)

Pfizer (PFE) has reported Treasury Shares for 18 consecutive years, with $115.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Treasury Shares changed 0.16% year-over-year to $115.2 billion in Q2 2026; TTM through Jun 2026 was $115.2 billion, a 0.16% change from a year earlier, with the FY2025 full-year figure at $115.0 billion, changed 0.22% from the prior year.
• Treasury Shares was $115.2 billion for Q2 2026 at Pfizer, roughly flat from $115.2 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $3.9 billion in Q1 2026 and troughed at $3.9 billion in Q2 2022.
• A 5-year average of $3.9 billion and a median of $3.9 billion in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares soared 5624.1% in 2023 and climbed 0.16% in 2026, its largest moves.
• Over 5 years, Treasury Shares stood at $114.0 billion in 2022, then rose by 0.45% to $114.5 billion in 2023, then rose by 0.24% to $114.8 billion in 2024, then climbed by 0.22% to $115.0 billion in 2025, then rose by 0.16% to $115.2 billion in 2026.
• The last three Treasury Shares figures came in at $115.2 billion (Q2 2026), $115.2 billion (Q1 2026), and $115.0 billion (Q4 2025), per Business Quant data.